| Literature DB >> 25695320 |
Susan R Bohm, Keira Wickliffe Berger, Pamela B Hackert, Richard Renas, Suzanne Brunette, Nicole Parker, Carolyn Padro, Anne Hocking, Mary Hedemark, Renai Edwards, Russell L Bush, Yury Khudyakov, Noele P Nelson, Eyasu H Teshale.
Abstract
Hepatitis A virus (HAV) infections among persons with developmental disabilities living in institutions were common in the past, but with improvements in care and fewer persons institutionalized, the number of HAV infections has declined in these institutions. However, residents in institutions are still vulnerable if they have not been vaccinated. On April 24, 2013, a resident of a group home (GH) for adults with disabilities in southeast Michigan (GH-A) was diagnosed with hepatitis A and died 2 days later of fulminant liver failure. Four weeks later, a second GH-A resident was diagnosed with hepatitis A. None of the GH-A residents or staff had been vaccinated against hepatitis A. Over the next 3 months, six more cases of hepatitis A were diagnosed in residents in four other Michigan GHs. Three local health departments were involved in case investigation and management, including administration of postexposure prophylaxis (PEP). Serum specimens from seven cases were found to have an identical strain of HAV genotype 1A. This report describes the outbreak investigation, the challenges of timely delivery of PEP for hepatitis A, and the need for preexposure vaccination against hepatitis A for adults living or working in GHs for the disabled.Entities:
Mesh:
Year: 2015 PMID: 25695320 PMCID: PMC4584704
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Epidemiologic and clinical summary of hepatitis A cases among residents of group homes — Michigan, April–July 2013
| Case no. | Group home | Work site | Age (yrs) | Sex | Illness onset date | Date of diagnosis | Clinical/Laboratory results | Symptoms |
|---|---|---|---|---|---|---|---|---|
| 1 | A | None | 48 | M | 4/16 | 4/24 | IgM anti-HAV+; ALT 2,525 U/dL; AST 4,530 U/dL | Yellow sclera, dark urine |
| 2 | A | A | 45 | M | 5/4 | 5/16 | IgM anti-HAV+; ALT 436 U/dL; AST 175 U/dL | Lethargic, chalky stools, dark urine, diarrhea, jaundice |
| 3 | B | B | 47 | M | 5/17 | 5/21 by clinical laboratory; 5/31 confirmed by MDCH laboratory | IgM anti-HAV+; ALT 693 U/dL; AST 118 U/dL | Painless jaundice, no other symptoms |
| 4 | C | B | 49 | M | 5/23 | 5/26 | IgM anti-HAV+; ALT 1,314 U/dL; AST 463 | Weak, difficulty standing |
| 5 | B | C | 42 | M | 5/28 | 5/29 | IgM anti-HAV+; ALT 4,946 U/dL; AST 4,521 U/dL | Jaundice, dark urine, decreased appetite |
| 6 | B | D | 49 | M | 5/29 | 5/30 | IgM anti-HAV+; ALT 1,419 U/dL; AST 792 U/dL | Abdominal pain, decreased appetite |
| 7 | D | E | 45 | M | 7/5 | 7/10 | IgM anti-HAV+; ALT 2,434 U/dL; AST 2,082 U/dL | Nausea, vomiting, orange urine, jaundice |
| 8 | E | F | 61 | F | 7/23 | 7/25 | IgM anti-HAV+; ALT 1,291 U/dL; AST 980 U/dL | Jaundice |
Abbreviations: IgM = immunoglobulin M; HAV = hepatitis A virus; ALT = alanine aminotransferase; AST = aspartate aminotransferase; MDCH = Michigan Department of Community Health.
FIGURE 1Number of laboratory-confirmed hepatitis A cases among residents of group homes, by illness onset date — Michigan, April–July 2013
FIGURE 2Schematic of the suspected route of transmission of hepatitis A virus among residents of group homes and their work sites — Michigan, April–July 2013
Abbreviations: GH = group home; WS = work site; PEP = postexposure prophylaxis; CR = co-resident; HCW = health care worker.
Number of persons who received postexposure prophylaxis (PEP) and date of PEP among group home and work site contacts of persons with hepatitis A infection* — Michigan, April–July 2013
| Case no. | Group home | Work site | No. of group home contacts | Group home contacts who received PEP | PEP dates at group homes | No. of work site contacts | Work site contacts who received PEP | PEP dates at work sites | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
| No. | (%) | No. | (%) | |||||||
| 1 | A | None | 18 | 18 | (100) | Vaccine: 4/29–5/3, 5/15; IG: 5/17 | N/A | N/A | N/A | |
| 2 | A | A | 18 | 18 | (100) | Vaccine: 4/29–5/3, 5/15; IG: 5/17 | 12 | 8 | (66.7) | 6/10 |
| 3 | B | B | 19 | 13 | (68.4) | 5/31–6/6 | 55 | 53 | (96.4) | 5/31–6/6 |
| 4 | C | B | 14 (2 previously vaccinated) | 14 | (100) | 6/3–6/24 | 55 | 53 | (96.4) | 5/31–6/6 |
| 5 | B | C | 19 | 13 | (68.4) | 5/31–6/6 | 4 | 4 | (100) | 6/5–6/11 |
| 6 | B | D | 19 | 13 | (68.4) | 5/31–6/6 | 57 | 46 | (80.7) | 6/1–6/17 |
| 7 | D | E | 13 (2 previously vaccinated) | 13 | (100) | 7/11–7/15 (2 received PEP at work site on 6/6) | 10 | 5 | (50) | 7/15–7/19 |
| 8 | E | F | 13 (1 previously vaccinated) | 12 | (92.3) | 7/30–8/2 (2 received PEP at work site on 6/10) | 45 | 39 | (86.7) | 7/29–7/31 |
| Camp | 70 staff and 89 campers from group home and private residences in 16 counties in Michigan | None | — | N/A | N/A | N/A | — | N/A | ||
Abbreviations: IG = immunoglobulin; N/A = not applicable.
Persons vaccinated against hepatitis A before the outbreak were not included among those needing PEP.
14-day period for effective PEP expired on day of notification about case. Campers were notified.